Hi pivalde. That was a great post. I believe those open label interim results were very positive. To see some efficacy at all in humans at this early stage is fantastic. They are the first human results after the animal models. As far as I know no other drug has demonstrated any efficacy against MSA. Most drugs fail during that step. PBT434 has crossed that step with strong evidence of efficacy in humans, with a double blind trial following close behind. The responders in the open label were all earlier stage, similar to the patients in the double blind.
201 is still a double blind, so by no means a slam dunk yet. but the risk of failure has been substantially reduced. I have no idea why the price would ease back on that news. Price manipulation maybe?
- Forums
- ASX - By Stock
- ATH
- What to hopefully look forward too
What to hopefully look forward too, page-12
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $5.491K | 1.520M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126437200 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.003 |
56 | 89498098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126437200 | 27 |
0.005 | 29143782 | 28 |
0.006 | 12098927 | 17 |
0.007 | 47601651 | 22 |
0.008 | 22833132 | 23 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online